Exploring the link between weight loss, sexual health, and medications like semaglutide can help both patients and health care providers understand what to expect and how to manage any changes
Most compounded semaglutide carries a BUD of 30 to 90 days from the date of compounding
Peptide origin / Partial sequence of human gastric protein BPC, isolated from gastric juice Molecular weight / Approximately 1,419 Da (15 amino acids) Common off-label oral dose / 250 to 500 mcg twice daily, taken on an empty stomach Common off-label subcutaneous dose / 200 to 300 mcg once or twice daily near the affected area or abdominally Evidence level / Preclinical only (GRADE: very low certainty for human GI healing) Key preclinical finding / Accelerated gastric ulcer healing in rats within 24 to 72 hours across multiple models Route preference for GI targets / Oral administration, based on topical mucosal contact rationale Safety profile in humans / Largely unknown
This conservative approach provides maximum receptor recovery and works well for long-term users planning multiple cycles over a year or more
PDE10 plays a crucial role in regulating cyclic nucleotide levels, which are key signaling molecules in the brain
Understanding these helps contextualise why swollen lymph nodes are unlikely to be related to Mounjaro